London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Visual rehabilitation by scleral fixation of posterior chamber Intraocular lenses in amblyopic aphakic children

Poster Details

First Author: M.Diaab SEYCHELLES

Co Author(s):    A. Samir   S. Eissa           

Abstract Details

Purpose:

To report on the outcome of scleral fixated posterior chamber intraocular lens (S-IOL) implantation in aphakic amblyopic children after 1 year.

Setting:

Magrabi hospital Damam ,KSA

Methods:

Amblyopic children with aphakia after traumatic and congenital cataract surgery unsuitable for spectacle or contact lens correction were operated with an anterior vitrectomy and inside-out double thread scleral fixation of an Alcon CZ70BD pcIOL. Refraction and vision was compared after 12 months.

Results:

23S-IOLs were implanted in 16 children aged 2-16 years: 10 eyes with traumatic [Group A], and 13 eyes with congenital cataracts [Group B]. Preoperative UCVA compared to postoperative UCVA improved in 9/10 eyes in group A and 12/13 eyes in group B. Preoperative BCVA Compared to postoperative UCVA improved in 9/10 eyes (90 percent) in group A and 4/13 eyes (31 percent) in group B. More than one year elapsed in 2/10 eyes of group Aand 8/13eyes in group B.Postoperative refraction was within 2.0D of target in 17/23 eyes. Complications included temporary IOP rise in 2,vitreous hemorrhage in 1,and iris capture in 3 eyes.

Conclusions:

S-IOL implantation may be beneficial for aphakic children lacking other means for visual rehabilitation to improve vision. Amblyopia may be improved in most trauma, but only few congenital cataract eyes.

Financial Disclosure:

NONE

Back to Poster listing